Target Audience and Goal Statement
This activity is intended for primary care clinicians, endocrinologists, diabetologists, and other allied healthcare professionals
who manage patients who are obese.
The goal of this activity is to focus on the global public health crisis of obesity and to demonstrate how motivational interview
techniques can be used by clinicians to help patients who are overweight or obese establish a partnership with their clinician
and foster patient adherence to an individualized weight loss management plan.
Upon completion of this activity, participants will be able to:
- Identify health consequences of untreated obesity and its association with the development and progression of comorbidities
- Translate techniques of motivational interviewing to increase provider-patient discussions regarding obesity management
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Moderator
Panelist
-
Caroline Apovian, MD
Director, Nutrition and Weight Management; Professor of Medicine and Pediatrics, Boston Medical Center, Boston University
School of Medicine, Boston, Massachusetts
Disclosures
Disclosure: Caroline Apovian, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amylin Pharmaceuticals, Inc.; Arena Pharmaceuticals, Inc.; EnteroMedics; Johnson &
Johnson Pharmaceutical Research & Development, L.L.C.; Merck & Co., Inc.; Nutrisystem, Inc.; Orexigen Therapeutics, Inc.;
Sanofi; Zafgen
Received grants for clinical research from: Amylin Pharmaceuticals, Inc.; Aspire Bariatrics, Inc.; Endo Barrier (GI Dynamics);
Lilly; MetaProteomics; Orexigen Therapeutics, Inc.; Pfizer Inc; Dr. Robert C. and Veronica Atkins Foundation; Sanofi
Dr Apovian does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Apovian does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
Editors
Steering Committee
-
Ken Fujioka, MD
Director, Nutrition and Metabolic Research Center, Scripps Clinic, La Jolla, California
Disclosures
Disclosure: Ken Fujioka, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Orexigen Therapeutics, Inc.; Novo Nordisk; Enteromedics, Inc.; Zafgen; NPS Pharmaceuticals,
Inc.; Eisai, Inc.; NaZura BioHealth, Inc.; Pathway Genomics Corporation; Isis Pharmaceuticals, Inc.
Served as a speaker or a member of a speakers bureau for: Abbott Laboratories; NPS Pharmaceuticals, Inc.; Eisai, Inc.; VIVUS
Inc.
Received grants for clinical research from: Orexigen Therapeutics, Inc.; Novo Nordisk; Enteromedics, Inc.; Shire, NPS Pharmaceuticals,
Inc.; Eisai, Inc.; Weight Watchers
-
Timothy Garvey, MD
Butterworth Professor and Chair, Department of Nutrition Sciences, University of Alabama at Birmingham; Director, University
of Alabama at Birmingham Diabetes Research Center; Investigator and Staff Physician, Geriatric Research, Education, and Clinical
Center, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama
Disclosures
Disclosure: Timothy Garvey, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Daiichi Sankyo, Inc.; VIVUS Inc.; Eisai, Inc.; Takeda Pharmaceuticals North America,
Inc.; Novo Nordisk; Janssen Pharmaceuticals, Inc.; LipoScience Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Merck & Co., Inc.; Weight Watchers; Sanofi; Eisai,
Inc.
Owns stocks, stocks options, or bonds from: Pfizer, Inc.; Lilly; Merck & Co., Inc.; Isis Pharmaceuticals, Inc.; Bristol-Myers
Squibb Company; Novartis Pharmaceuticals Corporation
-
Patrick O'Neil, PhD
Director, Weight Management Center; Professor, Department of Psychiatry and Behavioral Sciences; Professor, Department of
Surgery, Medical University of South Carolina, Charleston, South Carolina
Disclosures
Disclosure: Patrick O'Neil, PhD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Eisai Inc.; Novo Nordisk
Received grants for clinical research from: Orexigen Therapeutics, Inc.; Weight Watchers; Novo Nordisk
Received reimbursement for travel expenses from: VIVUS, Inc.
-
Steven R. Smith, MD
Professor, Sanford-Burnham Medical Research Institute; Chief Scientific Officer/Senior Vice President, Florida Hospital; Scientific
Director, Translational Research Institute for Metabolism and Diabetes, Orlando, Florida
Disclosures
Disclosure: Steven R. Smith, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amylin Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.; Arena Pharmaceuticals,
Inc.; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals Inc.; Bristol Meyers Squibb Company; Eisai, Inc.;
Elcelyx Therapeutics, Inc.; Lilly; FivePrime Therapeutics; GlaxoSmithKline; NGM Biopharmaceuticals, Inc.; Novo Nordisk; Orexigen
Therapeutics, Inc.; Piramal Life Sciences; Takeda Pharmaceuticals North America, Inc.; Zafgen
Received grants for clinical research from: Amylin Pharmaceuticals, Inc.; Lilly; Takeda Pharmaceuticals North America, Inc.
Owns stocks, stocks options, or bonds from: Jenrin Discovery Inc; Zafgen
CME Reviewer(s)
Accreditation Statements
For Physicians
-
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
Medscape, LLC designates this enduring material for a maximum of 0.50
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.